Distinct genomic features across cytolytic subgroups in skin melanoma.
Constantinos RoufasIlias Georgakopoulos-SoaresApostolos ZaravinosPublished in: Cancer immunology, immunotherapy : CII (2021)
Overall, our data highlight the existence of distinct genomic features across cytolytic subgroups in skin melanoma, which might affect the patients' relapse rate or their acquisition of resistance to immune checkpoint inhibition therapies.